State-of-the-art tools unveil potent drug targets amongst clinically approved drugs to inhibit helicase in SARS-CoV-2.

Autor: Borgio, J. Francis1,2, Alsuwat, Hind Saleh1, Otaibi, Waad Mohammed Al1, Ibrahim, Abdallah M.1,3, Almandil, Noor B.4, Asoom, Lubna Ibrahim Al5, Salahuddin, Mohammed6, Kamaraj, Balu7, AbdulAzeez, Sayed1 asayed@iau.edu.sa
Zdroj: Archives of Medical Science. 2020, Vol. 16 Issue 4, p508-518. 11p.
Databáze: Academic Search Ultimate